Development and validation of a high-sensitivity assay for measuring p217+tau in plasma.

Alzheimer's disease biomarker p212tau p217tau phosphorylation plasma tau

Journal

Alzheimer's & dementia (Amsterdam, Netherlands)
ISSN: 2352-8729
Titre abrégé: Alzheimers Dement (Amst)
Pays: United States
ID NLM: 101654604

Informations de publication

Date de publication:
2021
Historique:
received: 26 03 2021
revised: 28 04 2021
accepted: 03 05 2021
entrez: 7 6 2021
pubmed: 8 6 2021
medline: 8 6 2021
Statut: epublish

Résumé

Diagnosis of Alzheimer's disease (AD) based on amyloid beta (A), pathologic tau (T), and neurodegeneration (N) biomarkers in peripheral fluids promises to accelerate clinical trials and intercept disease earlier. Qualification of a Simoa plasma p217+tau assay was performed, followed by clinical utility evaluation in a cohort of 227 subjects with broad A and T spectrum. The p217+tau plasma assay was accurate, precise, dilution linear, and highly sensitive. All measured samples were within linear range of the assay, presented higher concentration in AD versus healthy controls ( The assay described here exhibits good technical performance and shows potential as a highly accurate peripheral biomarker for A or T status in AD and cognitively normal subjects.

Identifiants

pubmed: 34095436
doi: 10.1002/dad2.12204
pii: DAD212204
pmc: PMC8158165
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e12204

Informations de copyright

© 2021 The Authors. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring published by Wiley Periodicals, LLC on behalf of Alzheimer's Association.

Déclaration de conflit d'intérêts

G.T.B., S.M., K.V.K., C.T., R.S., M.M., and H.K. are employees of Janssen Research and Development, a pharmaceutical company of Johnson and Johnson.

Références

J Prev Alzheimers Dis. 2019;6(4):248-255
pubmed: 31686097
Brain. 2018 May 1;141(5):1517-1528
pubmed: 29538647
JAMA Neurol. 2019 Aug 1;76(8):915-924
pubmed: 31157827
Nat Commun. 2020 Apr 3;11(1):1683
pubmed: 32246036
Int J Mol Sci. 2017 Sep 13;18(9):
pubmed: 28902142
Eur J Biochem. 1998 Mar 15;252(3):542-52
pubmed: 9546672
Neuron. 2018 Mar 21;97(6):1284-1298.e7
pubmed: 29566794
J Neurol Neurosurg Psychiatry. 2015 Mar;86(3):244-50
pubmed: 24899730
Alzheimers Res Ther. 2018 Mar 20;10(1):33
pubmed: 29558986
Sci Transl Med. 2016 May 11;8(338):338ra66
pubmed: 27169802
Nat Med. 2020 Mar;26(3):398-407
pubmed: 32161412
JAMA Neurol. 2021 Feb 1;78(2):149-156
pubmed: 33165506
J Alzheimers Dis. 2016;51(4):1033-43
pubmed: 26923020
Neurology. 2013 May 7;80(19):1778-83
pubmed: 23390181
J Exp Med. 2020 Nov 2;217(11):
pubmed: 32725127
J Proteome Res. 2016 Feb 5;15(2):667-76
pubmed: 26742856
Lancet Neurol. 2016 Jun;15(7):673-684
pubmed: 27068280
JAMA. 2020 Aug 25;324(8):772-781
pubmed: 32722745
Brain. 2021 Mar 3;144(2):515-527
pubmed: 33283854
J Cell Mol Med. 2009 Sep;13(9A):2911-25
pubmed: 18657226
Clin Lab. 2014;60(4):629-34
pubmed: 24779297
PLoS One. 2013 Oct 07;8(10):e76523
pubmed: 24116116
J Biol Chem. 2007 Aug 10;282(32):23645-54
pubmed: 17562708
Eur J Biochem. 1986 Jan 2;154(1):41-8
pubmed: 3943524
Prog Neurobiol. 2008 Jun;85(2):148-75
pubmed: 18448228
Brain. 2016 Aug;139(Pt 8):2249-60
pubmed: 27286736
Natl Vital Stat Rep. 2018 Jul;67(6):1-77
pubmed: 30248017
Ann Neurol. 2012 Nov;72(5):648-72
pubmed: 23280789
J Cereb Blood Flow Metab. 2013 Oct;33(10):1500-13
pubmed: 23921899
Arch Neurol. 2009 Mar;66(3):382-9
pubmed: 19273758
Ann Clin Transl Neurol. 2019 Sep;6(9):1815-1824
pubmed: 31464088
J Alzheimers Dis. 2020;77(4):1397-1416
pubmed: 32894244
Neurobiol Aging. 2016 Jan;37:58-65
pubmed: 26508157
Acta Neuropathol. 2019 Feb;137(2):279-296
pubmed: 30547227
Acta Neurobiol Exp (Wars). 2012;72(3):264-71
pubmed: 23093013
Alzheimers Res Ther. 2020 Mar 17;12(1):26
pubmed: 32183883
EMBO Mol Med. 2019 Dec;11(12):e11170
pubmed: 31709776
J Alzheimers Dis. 2020;77(4):1417-1430
pubmed: 32831201
Neurology. 2016 Oct 25;87(17):1827-1835
pubmed: 27694257
PLoS One. 2018 Apr 11;13(4):e0194802
pubmed: 29641555
Alzheimers Res Ther. 2019 Apr 22;11(1):34
pubmed: 31010420
N Engl J Med. 2014 Jan 23;370(4):322-33
pubmed: 24450891

Auteurs

Gallen Triana-Baltzer (G)

Neuroscience Biomarkers Janssen Research & Development La Jolla California USA.

Setareh Moughadam (S)

Neuroscience Biomarkers Janssen Research & Development La Jolla California USA.

Randy Slemmon (R)

Neuroscience Biomarkers Janssen Research & Development La Jolla California USA.

Kristof Van Kolen (K)

Neuroscience Department Janssen Research & Development Beerse Belgium.

Clara Theunis (C)

Neuroscience Department Janssen Research & Development Beerse Belgium.

Marc Mercken (M)

Neuroscience Department Janssen Research & Development Beerse Belgium.

Hartmuth C Kolb (HC)

Neuroscience Biomarkers Janssen Research & Development La Jolla California USA.

Classifications MeSH